The company aims to advance breath analysis technology for the early screening of life threatening diseases.
Quote | Breathtec Biomedical Inc (OTCMKTS:BTHCF)
Last: | $ |
---|---|
Change Percent: | 10.19% |
Open: | $0.04 |
Close: | $0.04 |
High: | $0.04 |
Low: | $0.04 |
Volume: | 400 |
Last Trade Date Time: | 12/30/2019 09:43:33 am |
News | Breathtec Biomedical Inc (OTCMKTS:BTHCF)
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company announces that NP-120 (Ifenpro...
VANCOUVER, British Columbia, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that Dr. Mar...
Message Board Posts | Breathtec Biomedical Inc (OTCMKTS:BTHCF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Breathtec Biomedical Inc Company Name:
BTHCF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company announces that NP-120 (Ifenpro...
VANCOUVER, British Columbia, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that Dr. Mar...
VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that it will...